Health Alliance HMO-POS
Michael Zochert, LMHC
Counseling*
Age 50
Be the first to review this provider!
Offers telehealth
Michael Zochert, LMHC
Be the first to review this provider!
Cedar Rapids, IA
Accepting new patients
Offers telehealth
Clinical Overview
Michael Zochert, LMHC works in Cedar Rapids, IA as
Offers Telehealth
This provider offers telehealth appointments. Call the office to schedule.
COMPARE OTHER TOP Counselors
Contrast Michael Zochert with other nearby specialists.
Sandie Kreiser, LSCSW
Learn More
Katie Evans, LCMFT
Learn More
Laith Gulli, LMFT
Learn More
Susan Rhoads, LCSW
Learn More
Kendrick Cronin, LPCC
Learn More
Shannon Matthews, LCSW
Learn More
These providers are on the medical staff of Brightside.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Open Access PlusCigna PPOLocalPlus
-
Premier Care Network Plus - Innovation HealthAetna HMOOpen Choice PPOAPCN Choice POS IIElect Choice (Open Access) EPOManaged Choice (Open Access) POSChoice Plus POS II
-
First Health (Coventry Health Care) PPO
-
BlueCard PPO
-
Blue Cross Blue Shield of Illinois PPO
-
HealthyBlue Advantage
-
Health Alliance PPO
Office Locations
-
Cedar Centre Psychiatric Group1730 1st Ave NE, Cedar Rapids, IA 52402
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Michael Zochert?
Step 1 of 3
Your review of Michael Zochert, LMHC
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Counseling
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Michael Zochert, LMHC accepts new patients on Medical News Today.
Michael Zochert accepts telehealth appointments. Please call Michael Zochert's office to make an appointment.
Michael Zochert accepts Health Alliance, Cigna, Aetna, First Health, Blue Cross Blue Shield, Blue Cross and Blue Shield of Illinois, CareFirst BlueCross BlueShield and HAP Insurance as well as many others. See all of the insurances Michael Zochert accepts here.
Michael Zochert's office is located at 1730 1st Ave NE Cedar Rapids, IA 52402. Get a map and directions to Michael Zochert's office here.
Michael Zochert does not have any reviews yet.
Claim Your Profile
Are you Michael Zochert, LMHC?
Telehealth Options
This provider has not specified a telehealth appointment method. Would you still like to make an appointment with Michael Zochert?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A study found that people who used estrogen-only menopausal hormonal therapy were less likely to show increased Alzheimer’s disease pathology, and lower chances of memory decline and a dementia diagnosis.
On August 10, 2026, President Donald Trump signed an executive order recommending separate measles, mumps and rubella vaccinations. Medical experts explain why this recommendation is controversial.
New preclinical research has made a key discovery regarding the spread of ovarian cancer after chemotherapy. Fructose may play a role, it found.
